Dr. Paul R. Fortin, MD, MPH, FRCPC holds the Tier 1 Canada Research Chair in Systemic Autoimmune Rheumatic Diseases, is Professor at Laval University, and Clinical Investigator at the CHU Research Center of Quebec – Laval University. He obtained his medical degree from Laval University and is a graduate of McGill University in rheumatology. He then obtained a Master’s in Public Health from Harvard University’s School of Public Health.

Dr. Fortin is working to better understand the bio-psycho-social impact of systemic autoimmune rheumatic diseases (SARD), such as systemic lupus erythematosus (SLE), rheumatoid arthritis (RA), systemic sclerosis, inflammatory myositis, and antiphospholipid syndrome (APS). He is particularly interested in the development of interventions for the treatment of SLE, RA, and APS.

His methodological interests are the development and validation of diagnostic and prognostic tests, new treatments, and new ways to measure the impact of these treatments on the health status of the patient, and on the levels of activity or harm of the disease within SARDs. His other methodological interests include developing healthy lifestyle habits for people with SARD, and measuring the impact of patient knowledge.

Since 2011, Dr. Fortin has been working on the creation and establishment of a new computerized database and biobank that enables the collection of informative biospecimens and clinical data relevant to the study of SARDs. This biobank and database now has more than 13,000 biospecimens, from over 250 people, and has already contributed to translational and clinical research projects, as well as two projects funded by the Canadian Institutes of Health Research.

Dr. Fortin received the Canadian Rheumatology Association (CRA) Young Investigator Award in 1999, the Kirkland Scholar Award in 2008, and the prestigious Research Achievement Award from The Arthritis Society of Canada (2007- 2012). In 2010, he received the Lupus Ontario Hope Award for his outstanding leadership in improving the lives of people with lupus. In May 2015, he received the Jeffrey Shiroky Research Award for his clinical research achievements in rheumatology.

CHUL
2705, boulevard Laurier
TR-97
Québec, Québec
Canada G1V 4G2
331 entries « 1 of 34 »

Hasse S, Duchez AC, Fortin P, Boilard E, Bourgoin SG

Interplay between LPA2 and LPA3 in LPA-mediated phosphatidylserine cell surface exposure and extracellular vesicles release by erythrocytes.

Journal Article

Biochem Pharmacol, 192 , 2021.

Abstract | Links:

Hanly JG, Gordon C, Bae SC, Romero-Diaz J, Sanchez-Guerrero J, Bernatsky S, Clarke AE, Wallace DJ, Isenberg DA, Rahman A, Merrill JT, Fortin PR, Gladman DD, Urowitz MB, Bruce IN, Petri M, Ginzler EM, Dooley MA, Ramsey-Goldman R, Manzi S, Jonsen A, Alarcon GS, van Vollenhoven RF, Aranow C, Mackay M, Ruiz-Irastorza G, Lim SS, Inanc M, Kalunian KC, Jacobsen S, Peschken CA, Kamen DL, Askanase A, Farewell V

Neuropsychiatric Events in Systemic Lupus Erythematosus.

Journal Article

Arthritis Rheumatol, 2021.

Abstract | Links:

Vaillancourt M, Desaulniers P, Pare G, Page N, Lachhab A, Kerever A, Julien AS, Amiable N, Pelletier M, Tessier PA, Bessette L, Michou L, Fortin PR, Fernandes MJ

Expression of the myeloid inhibitory receptor CLEC12A correlates with disease activity and cytokines in early rheumatoid arthritis.

Journal Article

Sci Rep, 11 (1), 2021.

Abstract | Links:

Merrill JT, Bruce IN, Wallace D, Nived O, Ramsey-Goldman R, Sanchez-Guerrero J, Aranow C, Manzi S, Gladman DD, Kalunian K, Werth VP, Zoma A, Khamashta M, Buyon JP, Dooley MA, van Vollenhoven R, Ginzler E, Stoll T, Peschken C, Jorizzo JL, Callen JP, Inanç M, Kamen DL, Rahman A, Steinsson K, Magder LS, Petri M, Goldman DW, Alarcón GS, Gordon C, Fortin PR, Isenberg D, Bae SC, Hanly JG, Clarke AE, Urowitz M, Bernatsky S, Jacobsen S, Lim S, Franks AG

Comparison of the 2019 European Alliance of Associations for Rheumatology/American College of Rheumatology Systemic Lupus Erythematosus Classification Criteria With Two Sets of Earlier Systemic Lupus Erythematosus Classification Criteria.

Journal Article

Arthritis Care Res (Hoboken), 73 (9), 2021.

Abstract | Links:

Melki I, Allaeys I, Tessandier N, Levesque T, Cloutier N, Laroche A, Vernoux N, Becker Y, Benk-Fortin H, Zufferey A, Rollet-Labelle E, Pouliot M, Poirier G, Patey N, Belleannee C, Soulet D, McKenzie SE, Brisson A, Tremblay ME, Lood C, Fortin PR, Boilard E

Platelets release mitochondrial antigens in systemic lupus erythematosus.

Journal Article

Sci Transl Med, 13 (581), 2021.

Abstract | Links:

Mai L, Asaduzzaman A, Noamani B, Fortin PR, Gladman DD, Touma Z, Urowitz MB, Wither J

The baseline interferon signature predicts disease severity over the subsequent 5 years in systemic lupus erythematosus.

Journal Article

Arthritis Res Ther, 23 (1), 2021.

Abstract | Links:

Chew C, Reynolds JA, Lertratanakul A, Wu P, Urowitz M, Gladman DD, Fortin PR, Bae SC, Gordon C, Clarke AE, Bernatsky S, Hanly JG, Isenberg D, Rahman A, Sanchez-Guerrero J, Romero-Diaz J, Merrill J, Wallace D, Ginzler E, Khamashta M, Nived O, Jonsen A, Steinsson K, Manzi S, Kalunian K, Dooley MA, Petri M, Aranow C, van Vollenhoven R, Stoll T, Alarcon GS, Lim SS, Ruiz-Irastorza G, Peschken CA, Askanase AD, Kamen DL, Inanc M, Ramsey-Goldman R, Bruce IN

Lower vitamin D is associated with metabolic syndrome and insulin resistance in systemic lupus: data from an international inception cohort.

Journal Article

Rheumatology (Oxford), 2021.

Abstract | Links:

Elkhalifa M, Orbai AM, Magder LS, Petri M, Alarcon GS, Gordon C, Merrill J, Fortin PR, Bruce IN, Isenberg D, Wallace D, Nived O, Ramsey-Goldman R, Bae SC, Hanly JG, Sanchez-Guerrero J, Clarke AE, Aranow C, Manzi S, Urowitz M, Gladman DD, Kalunian K, Werth VP, Zoma A, Bernatsky S, Khamashta M, Jacobsen S, Buyon JP, Dooley MA, Vollenhoven RV, Ginzler E, Stoll T, Peschken C, Jorizzo JL, Callen JP, Lim S, Inanc M, Kamen DL, Rahman A, Steinsson K, Franks Jr

Anti-beta 2 glycoprotein I IgA in the SLICC classification criteria dataset.

Journal Article

Lupus, 30 (8), 2021.

Abstract | Links:

Urowitz MB, Gladman DD, Farewell V, Su J, Romero-Diaz J, Bae SC, Fortin PR, Sanchez-Guerrero J, Clarke AE, Bernatsky S, Gordon C, Hanly JG, Wallace DJ, Isenberg DA, Rahman A, Merrill JT, Ginzler E, Alarcon GS, Chatham WW, Petri MA, Bruce IN, Khamashta MA, Aranow C, Dooley MA, Manzi S, Ramsey-Goldman R, Nived O, Jonsen A, Steinsson K, Zoma AA, Ruiz-Irastorza G, Lim SS, Kalunian KC, Inanc M, van Vollenhoven R, Ramos-Casals M, Kamen DL, Jacobsen S, Peschken CA, Askanase A, Stoll T

Accrual of Atherosclerotic Vascular Events in a Multicenter Inception Systemic Lupus Erythematosus Cohort.

Journal Article

Arthritis Rheumatol, 72 (10), 2020.

Abstract | Links:

Legge A, Kirkland S, Rockwood K, Andreou P, Bae SC, Gordon C, Romero-Diaz J, Sanchez-Guerrero J, Wallace DJ, Bernatsky S, Clarke AE, Merrill JT, Ginzler EM, Fortin PR, Gladman DD, Urowitz MB, Bruce IN, Isenberg DA, Rahman A, Alarcon GS, Petri M, Khamashta MA, Dooley MA, Ramsey-Goldman R, Manzi S, Zoma AA, Aranow C, Mackay M, Ruiz-Irastorza G, Lim SS, Inanc M, van Vollenhoven RF, Jonsen A, Nived O, Ramos-Casals M, Kamen DL, Kalunian KC, Jacobsen S, Peschken CA, Askanase A, Hanly JG

Prediction of Damage Accrual in Systemic Lupus Erythematosus Using the Systemic Lupus International Collaborating Clinics Frailty Index.

Journal Article

Arthritis Rheumatol, 72 (4), 2020.

Abstract | Links:

331 entries « 1 of 34 »
Signaler des ajouts ou des modifications

Active projects

  • Canada research chair in Innovate Systemic Autoimmune Rheumatic Disease, from 2019-07-01 to 2026-06-30
  • Centre de recherche en arthrite (ARThrite), from 2020-11-03 to 2026-04-30
  • COVID-19 Vaccine in Immunosuppressed Adults with Autoimmune Diseases / La réponse immunitaire au vaccin contre la COVID-19 chez des patients immunosupprimés en raison de maladies auto-immunes, from 2021-03-16 to 2023-03-31
  • Hydroxychloroquine in systemic lupus, from 2018-04-01 to 2023-03-31
  • Mapping anti-mitochondrial antibodies in systemic lupus erythematosus, from 2019-04-01 to 2022-03-31
  • Platelets and neutrophils: the two culprits mediating pain in inflammatory arthritis, from 2020-04-01 to 2025-03-31
  • Platelets and neutrophils: the two culprits mediating pain in inflammatory arthritis, from 2020-01-01 to 2022-12-31
  • Projet de recherche sur les maladies arthritiques, from 2019-12-01 to 2021-11-30
  • The impact of antimalarial drugs in arthritis patients exposed to SARS-CoV-2- the CoVIRAL project, from 2020-04-01 to 2023-03-31
  • Unité support du Québec: Un soutien pour la recherche axée sur le patient., from 2014-04-01 to 2022-03-31

Recently finished projects

  • Centre de recherche en arthrite de l'Université Laval, from 2019-01-01 to 2020-01-31
  • Financement de projet de recherche clinique en rhumatologie, from 2020-01-06 to 2020-03-31
  • Maladies Rhumatismales Autoimmunes Systémiques (MRAS) , from 2020-12-15 to 2021-03-31
  • MyArthritisGuide for rheumatoid arthritis will improve patient's activation towards self-care, from 2018-07-01 to 2020-06-30
  • New statistical methods for cohort studies of adverse effects of medications, from 2016-07-01 to 2021-06-30
  • Platelets and their microparticles: versatile players of inflammation., from 2015-07-01 to 2020-06-30
  • Projet de recherche sur les maladies rhumatismales auto-immunes systémiques , from 2019-07-18 to 2020-03-31
  • Role of autotaxin bound to platelet-derived microparticles to development of vascular damage in arthritis., from 2015-07-01 to 2021-06-30
  • Support informatique (navigateur interactif en ligne) pour les patients souffrant d'arthrite rhumatoïde , from 2019-05-14 to 2020-03-31
  • Understanding the pathogenesis of COVID-19, from 2020-03-01 to 2021-02-28
Data provided by the Université Laval research projects registery